A newly-detected spinning galaxy filament is reshaping our understanding of cosmic structure, gas flows, and the origins of ...

Monday was quite the day for biotech companies developing the next generation of obesity drugs. One of them, Structure ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron that just showed positive results from a ...

Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...

The more researchers examine RNA, the more surprises they continue to uncover. What have we learned about RNA structure and function so far? Although RNA is a single-stranded molecule, researchers ...

Structure Therapeutics said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company's shares more than 140% higher.

Picture the most successful companies in the world; they have one thing in common — an effective organizational structure. But what exactly does that entail and how can it make or break a business? If ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas including investing, insurance portfolio management, finance and accounting, personal investment and financial ...